The main reason for this update is the integration of a beta version of OncoBox Colorectal 2.0. The beta version is intended for piloting OncoBox Colorectal 2.0 and includes the calculation of the basic data and the indicator sheet, as well as the other standard menus of OncoBox 2.0. The mapping of the Outcome Quality Matrix and the data sheet export has not yet been implemented in this beta version. These functionalities will be added shortly in a further update. Please note that the beta version of OncoBox Colorectal 2.0 is already aligned with the 2027 audityear, i.e. the indicators for the 2027 audityear are already being calculated.

Furthermore, at its meeting, the Certification Commission approved a revised and extended form of the basic data to be implemented from the 2028 audityear onwards. This particularly includes a separation of the basic data into colon and rectum, categorization according to UICC stages, and the mapping of recurrences and newly occurring distant metastases. The new form of the basic data is already mapped and calculated in OncoBox Colorectal 2.0. The “old” form of the basic data is no longer mapped in OncoBox Colorectal 2.0. For the 2027 audit year, the extended basic data will be converted into the currently valid form of the basic data when the data sheet is exported, once the data sheet export is available. The specification of OncoBox Colorectal 2.0, including the calculations, can be found below.

Furthermore, the sample patients have been updated based on feedback received from manufacturers.

The version 2.2.0 update also includes the following changes and bug fixes for Lung and Breast:

Application
Installer OncoBox 2.0 Auditjahr 2026 - Version 2.2.0

Specification
OncoBox Lunge 2.0 - Specification audityear 2026 Version 2.2.0
OncoBox Brust 2.0 - Specification audityear 2026 Version 2.2.0
OncoBox Darm 2.0 - Specification audityear 2027 Version 2.2.0-beta
OncoBox Darm 2.0 - Updated sample patients
OncoBox Darm 2.0 - XML-solution updated sample patients

At its meeting on 16 April 2026, the Certification Commission for Lung Cancer Centers approved changes and extensions to the KPI sheet. The changes approved for the indicator sheet require an extension of the OncoBox Lung 2.0 data field specification. Due to the relevance of these indicators, the data field specification for the 2027 audit year will be extended to include additional data fields in the sections Diagnosis, Histology, Radiotherapy, and Systemic Therapy.

In addition, the OncoBox Lung 2.0 data field specification will be harmonized, where relevant, with the data field specifications of the other OncoBox 2.0 organ entities (Breast and Colorectal). Therefore, further extensions to the data field specification will be implemented.

Furthermore, consent declarations for the transfer of OncoBox data to the planned DKG Research Platform and to the “Thorax-Doc” documentation platform of the German Society for Thoracic Surgery will be included in the data field “Study Name (Selection)”. Further information can be found in the explanatory notes for this data field in the data field specification.

Please refer to the Lung Data Field Specification for the 2027 audit year (changes are highlighted in color) and the attached updated XSD schema for all extensions to the XML interface.

The extensions will be implemented with the OncoBox 2.0 version for the 2027 audit year. This means that the interface to OncoBox Lung in the 2027 audit year can only be used based on the updated XSD schema. With the interim update, version 2.2.0 of OncoBox 2.0, the extended value sets and data fields can already be imported into OncoBox on an optional basis.

To maintain the conformity of the tumor documentation system with OncoBox Lung 2.0, the correct mapping of three additional sample patients is required by 31 January 2027.

OncoBox Lung 2.0 - Data field specification audityear 2027
OncoBox Lung 2.0 - xsd-schema audityear 2027
OncoBox Lunge 2.0 - Extension sample patients
OncoBox Lunge 2.0 - XML-solution extension sample patients

Following the OncoBox Lung 2.0, OncoBox Breast 2.0 and OncoBox Colorectal 2.0, a new OncoBox Prostate 2.0 will also be introduced. Development of the OncoBox Prostate 2.0 has now started. It is based on the cross-organ concept of the OncoBox 2.0 generation.

As a first step, the corresponding data field specification will be published. It will serve as a basis for the developers of the tumour documentation systems to implement the new XML interface.

The release of a first beta application is planned for early next year. In the medium term, the new OncoBox Prostate 2.0 is intended to replace the current OncoBox Prostate 1.0.

As part of the development of the new OncoBox Colorectal 2.0, it became necessary to add a new data field to the data field specification. This extended field in the "Distant metastases" section is intended to enable assignment of distant metastases to a colon or rectal diagnosis. This is particularly relevant for center cases with exclusively distant metastasis and a previous metachronous or synchronous colon and rectal diagnosis.

As part of this addition, the sample patients were also expanded and minor corrections were made. The updated sample patient datasets must be used/mapped for the first verification step.

The updated specification, the XSD validation schema, the sample patients and the XML sample solution are available for download on the "For Vendors" page.

Beispielpatientendatensaetze
XML sample for the example patient data sets
XML Schema Definition
Specification

In this issue of the OncoBox 2.0 newsletter, we once again provide an update on the current status of the integration of tumour documentation systems with OncoBox 2.0 (breast / lung), on the forthcoming mandatory implementation of OncoBox Lung from 2027, and on other current topics: OncoBox Colorectal 2.0 at the addz conference in Rostock, funding for the EDIUM Rectum project, and reports and information on both past and upcoming OncoBox driving licence courses.

OncoBox 2.0 - Newsletter 03/2026

As part of the development of OncoBox Darm 2.0, we are pleased to publish here the sample data sets required for the first verification step of the tumour documentation systems.

The first verification step requires the sample patient data records to be entered into the tumour documentation system and then correctly exported as an XML file in accordance with the XSD schema. The XML export files are checked and evaluated by OnkoZert/ClarData. Systems that have successfully completed the first verification step are marked with a light green tick under ‘Verified Systems’.

In addition, minor corrections and additions were necessary to the version of the data field specification last published on 2 April 2026. These changes are highlighted in colour in the updated version. The associated XSD validation schema has also been adjusted accordingly.

Note for colorectal cancer centres: This is not an update to the existing OncoBox Darm 1.0 for the 2026 audit year, but a new development as part of the new OncoBox 2.0 generation. OncoBox Darm 2.0, which is currently under development, will be piloted next year and is intended to replace the existing OncoBox Darm 1.0 in the medium term.

Beispielpatientendatensaetze
XML sample for the example patient data sets
XML Schema Definition
Specification

In this issue of the OncoBox 2.0 newsletter, we provide an update on the current status of the integration of tumour documentation systems with OncoBox 2.0 (breast / lung) and announce the start of development for OncoBox Darm 2.0. In addition, we report on the OncoBox driving licence courses held over the last two months, as well as new dates for the second half of 2026. Finally, there is an interview with our Master’s student Saskia Schroth, who has scientifically evaluated the OncoBox driving licence’s online learning platform for us.

Enjoy reading!

OncoBox 2.0 – Newsletter 02/2026

The data field specification for OncoBox Colorectal 2.0 and the corresponding XSD schema are hereby published. Tumor documentation providers may now begin implementing the XML interface.

A first version of the OncoBox Colorectal 2.0 application is expected to be available in autumn 2026, which is intended to replace OncoBox Darm 1.0 in the medium term. If you have any questions regarding OncoBox Colorectal 2.0, please contact (Vanessa Kolb: v.kolb (at) onkozert.de).

OncoBox Colorectal 2.0 specification
OncoBox Colorectal 2.0 XSD schema

With the update of OncoBox Prostate, a transfer error in the denominator for indicator 21 from OncoBox to the data sheet was corrected. In addition, a bug in the calculation of PCO indicators 1 and 2 was fixed.

For all audits of prostate cancer centers in 2026, the new OncoBox Prostate version Q1.2.1 must be used.

Application
OncoBox Prostata Q1.2.1

With the first issue of the OncoBox 2.0 Newsletter 2026, we once again provide information on the current status of the connection of tumor documentation systems to OncoBox 2.0 (breast / lung), the release of OncoBox Breast 2.0, OncoBox 2.0 at the German Cancer Congress, the new OncoBox license training dates for the second quarter, and the exchange between the German Cancer Society and OnkoZert/ClarData regarding the OncoBox environment shortly before Christmas.

Enjoy reading!

OncoBox 2.0 - Newsletter 01/2026

With the update to version 2.1.1 of the OncoBox 2.0, several enhancements were implemented and minor bugs fixed as part of the Breast 2.0 pilot project. For Lung, the OncoBox has been adapted to the 9th edition of the „TNM Classification of Malignant Tumours“. For the 2026 audit year, OncoBox Lung Version 2.1.0 or the new Version 2.1.1 (recommended in case of import problems) can be used.

The updated specifications with changes from the previous version can be downloaded below. The most important changes for Breast 2.0 and Lung 2.0 are listed in the following table:

Application
OncoBox 2.0 Audityear 2026 (Version 2.1.1)

Specification
OncoBox Lung 2.0 Specification Audityear 2026 (Version 2.1.1)
OncoBox Breast 2.0 Specification Audityear 2026 (Version 2.1.1)

With the introduction of OncoBox Lung, the new OncoBox 2.0 generation was launched. In 2025, it was already successfully used in audits. OncoBox Breast 2.0 was completed at the end of 2025 and will be piloted in 2026.As part of the conceptualization and development of OncoBox 2.0, there was intensive collaboration with subject matter experts, representatives of centers, and staff from OnkoZert and ClarData. During this process, the new OncoBox and its operation were also presented. It became evident that the OncoBox can be operated and used intuitively in many respects. Nevertheless, a certain level of background knowledge and practical exercises are essential to fully leverage the potential of the OncoBox.This insight led to the creation of the “OncoBox Driver’s License.” The OncoBox Driver’s License offers interested individuals the opportunity to acquire focused knowledge and practical skills in using OncoBox 2.0. This qualification is entirely optional. This means that the OncoBox can still be used within the certification process without this qualification certificate.

The following dates are available for the second quarter, including one “North” option in Hanover:

• Training Course “OncoBox Driver’s License” May 20/21, 2026 in Neu-Ulm
• Training Course “OncoBox Driver’s License” (North) June 22/23, 2026 in Hanover

Further information and registration details for the training courses can be found under OncoBox-Führerschein.

Due to adjustments to the data sheet (EXCEL) for the 2026 audit year and feedback from developers and centres this year, changes to the specification and the OncoBox Lung 2.0 application are necessary. The changes to the data sheet are already available on the OnkoZert-Website and will not be published again here.

The cross-organ assessment of outcome quality (EQ Performance and EQ Clinical) piloted this year in OncoBox Lung 2.0 will be included in the data sheet export for lung from the 2026 audit year onwards. The data on outcome quality is generated entirely via OncoBox. The data obtained across centres will be validated in its entirety by the end of the 2026 audit year at the latest and, if necessary, used for the further development of the assessment of outcome quality. No other assessment of outcome quality is required for centres using OncoBox Lung 2.0.

All changed spreadsheets are highlighted in colour in the table of contents of the OncoBox Lung 2.0 specification. In the following table, you can check the extent to which documentation practices or the export of OncoBox Lung 2.0 have changed.

With the updated version of OncoBox 2.0 for the 2026 audit year (version 2.1.0), a beta version of the new OncoBox Breast 2.0 is now also available. Alongside OncoBox Lung, OncoBox Breast is the second organ to be integrated into the OncoBox 2.0 application. The beta version is primarily intended for piloting the application. For the upcoming audit year 2026, OncoBox Breast 1.0 (version N1.1.1) or the new OncoBox Breast 2.0 can be used, provided that the tumour documentation system has a verified interface. Due to the optional nature of OncoBox Breast, the data sheet can also be filled out manually. From the 2027 audit year onwards, only OncoBox Breast 2.0 will be available; OncoBox Breast 1.0 will no longer be updated for the 2027 audit year.

Application
OncoBox 2.0 Auditjahr 2026 (Version 2.1.0)

Specification
OncoBox Lunge 2.0 Spezifikation Auditjahr 2026 (Version 2.1.0)
OncoBox Brust 2.0 Spezifikation Auditjahr 2026 (Version 2.1.0-beta)

The OncoBox Lung recently marked the launch of the new OncoBox 2.0 generation. It has already been successfully used in audits in 2025. Building on this experience, the OncoBox Breast 2.0 is currently being developed and is set to replace its predecessor in the medium term. During the design and development of the OncoBox 2.0, there was an intensive exchange with experts, representatives from centres and employees of OnkoZert and ClarData, during which the new OncoBox and its operation were also presented. This showed that the OncoBox can be operated and used intuitively in many ways. Nevertheless, a certain amount of background knowledge and practical exercises are essential in order to fully exploit the potential of the OncoBox. This insight led to the creation of the ‘OncoBox licence’. The OncoBox licence offers interested individuals the opportunity to acquire focused knowledge and skills in using the OncoBox 2.0. This qualification is purely optional. This means that the OncoBox can also be used for certification purposes without this qualification certificate.

Following the successful first OncoBox licence course in November 2025, new dates are now available for the first quarter of 2026.

• Wednesday/Thursday, 18/19 March 2026 (OncoBox licence only)
• Tuesday-Thursday, 17-19 March 2026 (combined course, see below)

For the 17–19 March date, a combination course entitled ‘Audit Vor-/Nachbereitung & OncoBox Führerschein’ will also be offered for the first time. Further information on the courses (solo and combination) can be found under OncoBox-Führerschein.

In the fourth edition of the OncoBox 2.0 newsletter, we provide an update on the current status of the interface of tumour documentation systems to OncoBox Lung, the progress made with OncoBox Breast 2.0, the importance of OncoBox for healthcare research, impressions from the 1st OncoBox licence course in November 2026, and the announcement of new course dates for the first quarter of 2026.

Enjoy reading!

OncoBox 2.0 - Newsletter 04/2025

Due to the adjustments to the data sheet (EXCEL) for the audityear 2026 and feedback from developers and centres this year, changes to the specification and the OncoBox are necessary. The changes to the data sheet are already shown on the OnkoZert-Website and will not be published here again.

In the table of contents of the respective OncoBox specification, all changed table sheets are marked in colour. In the table below, you can check the extent to which the documentation practice or export has changed for the OncoBox Breast, Colorectal and Prostate.

Application
OncoBox Brust N1.1.1
OncoBox Darm P1.1.1
OncoBox Prostata Q1.1.1

Specification
OncoBox Brust Spezifikation N1.1.1
OncoBox Darm Spezifikation P1.1.1
OncoBox Prostata Spezifikation Q1.1.1

As part of the development of OncoBox Breast 2.0, we are pleased to publish the sample data sets required for the first verification step of the tumour documentation systems. This marks the start of the verification process.

The first verification step requires the sample patient data sets to be entered into the tumour documentation system and then correctly exported as an XML file in accordance with the xsd schema. The XML export files are checked and evaluated by OnkoZert/ClarData. Systems that have successfully completed the first verification step are marked with a light green tick under ‘Verified Systems’.

In addition, minor corrections and additions to the version of the data field specification last published on 4th September 2025 were necessary. These changes are highlighted in colour in the updated version. The associated XSD validation schema has also been adapted accordingly.

Note for breast cancer centres: This is not an update of the existing OncoBox Breast 1.0 for the 2026 audit year, but a new development as part of the new OncoBox 2.0 generation. OncoBox Breast 2.0, which is currently under development, will be piloted next year and is expected to replace the existing OncoBox Breast 1.0 in the medium term. The update to the existing OncoBox Breast 1.0 for use by breast cancer centres for the 2026 audit year will be published in the coming weeks.

Beispielpatientendatensaetze
XML sample for the example patient data sets
XML Schema Definition
Specification

The OncoBox Lung recently marked the launch of the new OncoBox 2.0 generation. It has already been successfully used in audits in 2025. Building on this experience, the OncoBox Breast 2.0 is currently being developed and is set to replace its predecessor in the medium term. During the design and development of the OncoBox 2.0, there was an intensive exchange with experts, representatives from centres and employees of OnkoZert and ClarData, during which the new OncoBox and its operation were also presented. This showed that the OncoBox can be operated and used intuitively in many ways. Nevertheless, a certain amount of background knowledge and practical exercises are essential in order to fully exploit the potential of the OncoBox. This insight led to the creation of the ‘OncoBox driving licence’. The OncoBox licence offers interested individuals the opportunity to acquire focused knowledge and skills in using the OncoBox 2.0. This qualification is purely optional. This means that the OncoBox can also be used for certification purposes without this qualification certificate.

More information about the OncoBox licence workshop can be found at https://fuehrerschein.xml-oncobox.de/

In the third edition of the OncoBox 2.0 newsletter, we provide an update on the current status of the interface of tumour documentation systems to OncoBox Lung, including statements from developers who are currently developing the interface. We also provide information on the upcoming development of OncoBox Breast 2.0 and the "OncoBox Führerschein" workshop. Enjoy reading!

OncoBox 2.0 - Newsletter 03/2025

Following the successful piloting of OncoBox Lung as the first entity of the new OncoBox 2.0 generation, a new OncoBox Breast 2.0 will follow soon. The data field specification for OncoBox Breast 2.0 and the corresponding XSD schema are hereby published. The implementation of the XML interface by tumour documentation manufacturers can therefore already begin. A first version of the OncoBox Breast 2.0 application is expected to follow by the end of 2025. If you have any questions about OncoBox Breast 2.0, please contact Ms. Alicia Böttcher. (E-Mail: a.boettcher (at) onkozert.de).

XML Schema Definition
Specification

In the second edition of the OncoBox 2.0 newsletter, we provide information on the current status of the interface of tumour documentation systems to OncoBox Lung and on the piloting of Matrix outcome quality 2.0. You will also find reports on the experiences of two pilot centres. Enjoy reading!

OncoBox 2.0 - Newsletter 02/2025

With the update version 2.0.4 of the OncoBox Lung, enhancements have been implemented in several places and minor bugs have been fixed. An updated specification with changes compared to the previous version can be downloaded below. Only the new version 2.0.4 is to be used for audits in 2025.

A list of all relevant changes can be found in the following table:

Furthermore, version 2.0.4 pilots a new approach to the quality of results with the following 3 modules:

EQ Performance is intended to enable a standardized representation of the outcome quality results across all organs at calendar year level. Similar to the currently valid matrix for quality of outcome, the focus here is primarily on the follow-up rate with regard to the calendar year. This makes it possible to answer questions like: What is the current follow-up rate for cases between 2020 and 2022?

The EQ Clinical looks at the outcome quality of the case collective 1 year, 3 years, 5 years and 10 years after the case date/count date. In contrast to the EQ Performance, the evaluation time in the EQ Clinical is not the calendar year, but the periods after the case date. This makes it possible to answer questions like: How many cases have died after 3 years with an event?

The EQ indicators are intended to enable a structured evaluation of the outcome quality parameters, analogous to the existing key figure sheet, e.g. ‘How high is the overall survival after 3 years for primary cases stage III and IV’?

The new concepts for outcome quality also allow non-primary cases to be analyzed.

These new concepts are to be validated as part of the pilot program. They are not part of the certification and are not exported to the data sheet. You will find the corresponding concepts in the top menu ‘Ergebnisqualität (Pilot)’.

Application
OncoBox Lunge 2.0.4

Specification
OncoBox Lunge Spezifikation Auditjahr 2025 (Version 2.0.4)

With this newsletter, we would like to keep you up to date during the introduction of the OncoBox 2.0 environment in DKG-certified organ cancer centres (especially lung cancer centres). You will find answers to questions such as how many developers have already been successfully connected, how many centres have already used OncoBox 2.0, and what actions or infrastructural changes have already been made beyond the mere provision of OncoBox 2.0.

Enjoy scrolling through!

OncoBox 2.0 - Newsletter

Aufgrund der ProKontinenz-Studie wurden Änderungen in der OncoBox notwendig. Für ProKontinenz-Studienzentren ist es in der OncoBox Version P1.1.2 nun auch möglich, die ProKontinenz-Befragungsdaten einzulesen und zu betrachten (Gesamtbetrachtung ProKontinenz).

Die Änderungen betreffen nur ProKontinenz-Studienzentren. Für die Audits im Jahr 2025 ist diese Version nicht verpflichtend zu nutzen (P1.1.1 ist ebenfalls in Ordnung).

Zudem ist für alle nicht-deutschsprachigen Zentren nun auch der Download des englischen Datenblattes möglich.

Application
OncoBox Prostata P1.1.2

With the update version 2.0.2 of the OncoBox Lung, bugs in the indicator sheet were fixed and adjustments were made to the to-do list (conversion of certain deficits into notes). Furthermore, the encryption of the data export was updated for the DigiNet study. Only the new version 2.0.2 is to be used for the data delivery of the DigiNet study centres and for audits in 2025.

An updated specification with changes compared to the previous version can be downloaded here.

Furthermore, we are pleased that GTDS is the first tumour documentation system to be verified for the OncoBox Lunge. Together with a pilot centre, the system developer has successfully completed a two-stage verification process. From now on, all lung cancer centres that use GTDS for their tumour documentation can use OncoBox Lung version 2.0.2 for the audit.

Application
OncoBox Lung 2.0.2

Specification
OncoBox Lung specification audit year 2025 (version 2.0.2)

Due to the adjustments to the data sheet (EXCEL) for the audityear 2025 and feedback from developers and centres this year, changes to the specification and the OncoBox are necessary. The changes to the data sheet are already shown on the OnkoZert-Website and will not be published here again.

In the table of contents of the respective OncoBox specification, all changed table sheets are marked in colour. In the table below, you can check the extent to which the documentation practice or export has changed for the OncoBox Breast, Colorectal and Prostate.

*no action to be taken by centre or tumour documentation developer

The newly developed OncoBox Lung was updated after completion of the pilot phase based on feedback from pilot centres and system developers. A version for the 2025 audit year is available for download and can already be used for audits with verified tumour documentation systems. A list of the relevant changes compared to the beta version from the pilot was communicated separately to the active centres and system developers. Other developers and centres who would like a list of the relevant changes compared to the beta version can contact Mr Pauler l.pauler (at) onkozert.de) in this regard.

Application
OncoBox Brust M1.1.1
OncoBox Darm O1.1.1
OncoBox Prostata P1.1.1
OncoBox Lunge Auditjahr 2025 (vom 17.12.2024)

Specification
OncoBox Brust Spezifikation M1.1.1
OncoBox Darm Spezifikation O1.1.1
OncoBox Prostata Spezifikation P1.1.1
OncoBox Lunge Spezifikation Auditjahr 2025 (vom 17.12.2024)

The pilot phase of the OncoBox Lung begins. A beta version of the OncoBox Lung, which can be used by selected pilot centers, has been published today. If you are interested in participating in the pilot phase, please contact us. The requirement for a participation is a tumor documentation system with a completed 1st verification step (see systems with a light green tick in the “Verified Systems” tab). The beta version of OncoBox Lung includes an overall view, to-do list and case list. It also includes the calculation of the basic data and the indicator sheet for DKG certification (audit year 2024). An export of the DKG data sheet is also implemented. In the OncoBox Lung, it will be possible to document and save all reasons/causes and action taken/planned and non-calculable indicators. Note: The matrix is not yet part of the beta version and will be published in a later version.

An updated specification, including all current calculations by OncoBox (audit year 2024), can be downloaded.

Application
OncoBox Lung 2.0.0-beta

Specification
OncoBox Lung specification audit year 2024

The OncoBox Prostate update has corrected a bug in the calculation of indicator 17. In addition, the English data sheet is now also available in the OncoBox.

In the OncoBox Breast, a bug in the calculation of indicator 4 has been fixed. The English data sheet is now available in the OncoBox Breast as well.

The new OncoBox Prostate version O1.2.2 must be used for all audits of prostate cancer centers in 2024. For the optional use of the OncoBox in audits of DKG-certified breast cancer centers, the OncoBox Breast version L1.1.2 must be used.

Application
OncoBox Brust L1.1.2
OncoBox Prostata O1.2.2

Specification
OncoBox Brust Spezifikation L1.1.2
OncoBox Prostata Spezifikation O1.2.2

Due to adjustments to the data sheet (Excel) for the upcoming audit year 2024, changes to the specification and OncoBox are necessary. The new version of the OncoBox Prostate (O1.2.1) is now available. The changes in the data sheet are already shown on the OnkoZert-Website and will not be published here again.

In the table of contents of the OncoBox specification, all changed table sheets are highlighted in color. In the table below you can check to what extent something has changed in the documentation practice or export.

*no action to be taken by centre or tumour documentation developer

Application
OncoBox Prostata O1.2.1

Specification
OncoBox Prostata Spezifikation O1.2.1

Due to the adjustments to the data sheets (EXCEL) for the upcoming audit year 2024, changes to the specifications and OncoBoxes are necessary. The new versions of the OncoBox Breast (L1.1.1) and OncoBox Colorectal (N1.1.1) are already available. The changes in the data sheets for breast and colorectal are already shown on the OnkoZert-Website and will not be published here again. In the table of contents of the OncoBox specifications, all changed table sheets are highlighted in color. In the table below you can check to what extent something has changed in the documentation practice or export.

The new version of the OncoBox Prostate (O1.1.1) for the audit year 2024 is expected to be published in January, as the legislature has decided to make last-minute additions to the data sheet. The changes and additions to the prostate data sheet can also be viewed on the OnkoZert-Website. We will inform you on this website as soon as the OncoBox Prostate version for the audit year 2024 is available for installation.

Please note that our office will be closed between 21.12.23 and 06.01.24.

*no action to be taken by centre or tumour documentation developer

Application
OncoBox Brust L1.1.1
OncoBox Darm N1.1.1

Specification
OncoBox Brust Spezifikation L1.1.1
OncoBox Darm Spezifikation N1.1.1

As part of the verification process of the tumour documentation systems to the new OncoBox Lung, a beta version with partial functions is now available for the developers. The release of this version is intended exclusively for tumour documentation system developers for technical testing of their interface and not yet for use by lung cancer centers. The application can be downloaded from the "For developers" menu (tab "Lung"). The Excel-specification has also been expanded to include further relevant spreadsheets.

During the development of OncoBox Lung, it became apparent that locating the follow-up section at patient level is problematic. It was therefore necessary to restructure the system so that the follow-up is transmitted at case level and not at patient level. The adapted files (specification, xsd-schema, sample patient data sets) can be downloaded from the "For Developer" menu. Please note that the updated specification contains further 'minor' changes, which are marked in yellow/red:

• Field "Therapies distant metastases": removal of the value "Antibody therapy (AK)"
• The selection field "Name of study" has been renamed "Name of study (selection)" to ensure differentiation from the free text field "Name of study". This is merely a change in the specification; the xsd schema remains unchanged in this respect.
• The terminology of the histology codes ("Histologie Codes" spreadsheet in the specification) has been partially adapted. Furthermore, code 8013/3 was listed twice in the previous version. This has been corrected.

As part of the development and piloting of the OncoBox Lung, the following is the publication of the sample patient records that will be used for the 1st verification step in the tumor documentation manufacturer verification process. The 1st verification step for the tumor documentation manufacturers requires that the example patient records are correctly documented in the tumor documentation system and exported in the form of an XML file. A review/assessment of the XML export file is done by OnkoZert. Tumor documentation manufacturers with 1st verification step in progress are marked with a yellow tick under "Verified systems" in the "Lung" column. Tumor documentation systems with successfully completed 1st verification step are marked with a light green tick. After completion of the 2nd verification step, which involves the generation of the lung data sheet from a pilot center via the OncoBox, the tumor documentation system will be marked with a green check mark, analogous to the existing OncoBoxes.

Compared to the last published data field specification version of 22.12.2022, some corrections/additions in the data fields, XML names and explanatory texts were also necessary. These few changes are colored yellow in the data field specification and marked with red text. This also results in a modified XSD schema.

Specification
Spezifikation OncoBox Lunge

XML Schema Definition
XSD-Schema Zertifizierung-XML

OncoBox Compare is a tool for the direct electronic comparison of data from the cancer registry and a centre based on the OncoBox "Prostate". The aim of the comparison of the data is to determine the degree of conformity and the quality and, in the case of differences, to address the causes of the deficits if necessary. The system was tested in a joint project of OnkoZert and the Cancer Registry of Rhineland-Palatinate in cooperation with two Prostate Cancer Centres from Rhineland-Palatinate. One result of the project was that the conformity of the patient collectives and data fields could be significantly increased. The project was presented at the §65c platform meeting on 22.03.2023 as well as at the DVDM focus on 20.04.2023.

The project is now to be extended to further §65c cancer registries and to further Prostate Cancer Centres. So far, four more cancer registries have registered for the "OncoBox Compare". On 04.10.2023 (3 p.m.), a web telco will take place in which the project will be presented once again in principle. Further expressions of interest will then be accepted until 31.10.2023.

To register for the web telco, please send an informal email to:

Philipp Kachel (CIO Cancer Registry RLP; kachel@krebsregister-rlp.de) or Sebastian Dieng (OnkoZert / ClarData; s.dieng@onkozert.de

Due to the new PCO subproject MID-EPIC-D and the PRO-P study, changes to the specification and the OncoBox became necessary. For PCO study centers, the OncoBox version N1.2.1 now includes the 2-year survey (overall view and patient profile). For PRO-P study centers, the study patient selection and export functionality for forwarding study-relevant data to the PRO-P-Doc study documentation system has been implemented.

The changes only affect PCO and PRO-P study centers. It is not mandatory to use this version for the 2023 audits (N1.1.1 is also fine).

Application
OncoBox Prostata N1.2.1

Specification
OncoBox Prostata Spezifikation N1.2.1

This update fixes a bug in the representation of the matrix colon and matrix rectum. A new installation of the application is mandatory for all colorectal cancer centers.

The use of the new OncoBox version M1.1.2 is required for all audits from 01.06.2023.

Application
OncoBox Darm M1.1.2

Minor changes to the data field specification for OncoBox Lunge were already published on 09/08/2022. Due to further feedback, new requirements and technical restructuring, additional minor changes to the data field specification were now necessary. The changes have been implemented in this update to the specification (highlighted in yellow with red font). One restructuring that has been made is that the specific fields for the DigiNet study (first name, last name, date of birth, health insurance number) are no longer transmitted to OncoBox via the certification XML, but via a separate DigiNet XML (data field specification DigiNet XML is included in specification OncoBox Lung as a separate spreadsheet).

The XSD schema of the certification XML has also been adapted due to the changes in the data field specification, as well as the XML template and the guideline. No further changes to the data field specification are planned for the time being. The current version of the data field specification will be used to define the basic data and indicator calculations of OncoBox. To this end, we will release an update to the OncoBox Lung specification in the new year that will include these calculations.

The current version of the OncoBox Lung specification and the other files can be downloaded below:

Spezifikation OncoBox Lunge
XSD-Schema Zertifizierung-XML
XML-Template Zertifizierungs-XML
XSD-Schema DigiNet-XML
XML-Template DigiNet-XML
Leitfaden zur Schnittstelle

Due to changes in the data sheets (EXCEL) for the upcoming audit year 2023, we have made necessary adjustments to the specifications of the OncoBoxes. Changes in the data sheets which have previously been published on the OnkoZert-Website will not be published again. We would like to remind the users of the “OncoBox Prostate” and the PCO study centres to note once again that since version M1.1.1 (audit year 2022) it is possible to send surgeon pseudonyms via two additional XML tags (optional). Furthermore, we would like to point out to the users of OncoBox Breast that .NET Framework 4.8 is now also required, as it is for Prostate and Colorectal.

In the table of contents of the specification, all changed table sheets have been colour coded. In the table below you can check to what extent something has been changed in the documentation practice or in the export:

*no action to be taken by centre or tumour documentation developer

Application
OncoBox Brust K2.1.1
OncoBox Darm M1.1.1
OncoBox Prostata N1.1.1

Specification
OncoBox Brust Spezifikation K2.1.1
OncoBox Darm Spezifikation M1.1.1
OncoBox Prostata Spezifikation N1.1.1

On July 1st 2022, the first draft of the data field specification for the OncoBox Lung was published here. We have already received some feedback (mainly of a textual nature) from the tumour documentation software developers, which we have implemented in this small update of the specification (marked in yellow with red font). In addition, the XSD schema has been finalised. These files, a sample XML patient and the XML interface guide can be downloaded below.

Specification
Datenfeldspezifikation OncoBox Lunge
XSD-Schema
XML-Beispielpatient
XML-Template
Leitfaden zur Schnittstelle

As already announced at the end of 2021, an OncoBox Lung is currently being developed as part of the DigiNet project. The first draft for a data field specification is now available. Based on this data field specification, the pilot for the OncoBox Lung will be developed and the test and validation environment will be created. TDS manufacturers who have not yet expressed their interest in participating in the OncoBox Lung pilot can still register with OnkoZert for participation until 01.08.2022.

Specification
XML-Spezifikation OncoBox Lunge

For both OncoBox Breast and Prostate, we published updates including smaller changes which are only relevant for non-German speaking centres (generation of data sheet in English) and PCO study centres (pT0 after complete removal of tumour during biopsy is now a conspicuity only; EXCEL export 1 year patient monitor).

For the audits in 2022, you are not obliged to use these versions (Breast K1.1.2 and Prostate M1.1.1 will be also accepted).

Application
OncoBox Brust K1.1.3
OncoBox Prostata M1.2.1

Specification
OncoBox Brust Spezifikation K1.1.3
OncoBox Prostata Spezifikation M1.2.1

Due to changes in the data sheets (EXCEL) for the audit year 2021, we made necessary adaptions to the specification an the OncoBoxes. Changes in the data sheets which have been already shown on  OnkoZert-Website are not displayed again, as there is neither an impact on documentation praxis nor the export interface. In order to give the PCO centres the possibility to transmit also surgeons‘ pseudonyms, you can add two tags (optional) in OncoBox Prostate.

In the following table you can find to what extent something has changed in the documentation practice or in the export:

*no action to be taken by centre or tumour documentation developer

Application
OncoBox Brust K1.1.2
OncoBox Darm L1.1.1
OncoBox Prostata M1.1.1

Specification
OncoBox Brust Spezifikation K1.1.2
OncoBox Darm Spezifikation L1.1.1
OncoBox Prostata Spezifikation M1.1.1

In the framework of DigiNet (project funded by the Innovation fund), the OncoBox Lung will be developed in the upcoming years. Here, too, we are working on a first draft of the field specification. In the first step, the OncoBox Lung will be primarily used in the lung cancer centres who take also part in „DigiNet“. Tumor documentation developers who provide services to DigiNet centres will be contacted separately. If a tumour documentation developer would like to take part at the pilot project independant of DigiNet, can also utter its interest. (Luis Pauler: l.pauler (at) onkozert.de).

The current OncoBox Colorectal was developed in 2021. Since then, only adaptions had been made. This approach came up more and more often against technological limits. Further, functional developements had been put on hold (limitation on primary cases, lack of multilinguality). Therefore, the German Cancer Society and OnkoZert have decided to deploy a new OncoBox colorectal. Right now, we are working on a first draft of the field specification. For 2022, we plan first pilots. A wide distribution of the OncoBox is planned for the year 2023. Tumour documentation developers who would like to take part actively in the framework of the pilot project OncoBox Colorectal 2.0, are invited to utter their interest. (Luis Pauler: l.pauler (at) onkozert.de).

With this update, PCO study centers can now use the 1-year patient monitor. This enables the comparison of pre- and post-therapeutic survey results and thus offers prompt feedback after the post-therapeutic feedback from the patient in order to derive consequences for further treatment or to initiate internal learning processes. It is not mandatory to use this version for the audits in 2021.

Application
OncoBox Prostata L1.1.3

Specification
OncoBox Prostata Spezifikation L1.1.3

This update fixes a bug concerning total and single dose in Gray (dots instead of commas were not allowed). If the bug produces a docu deficit while importing the XML file into the OncoBox, you should use the new version.

Application
OncoBox Prostata L1.1.2

Specification
OncoBox Prostata Spezifikation L1.1.2

Due to changes in the data sheets (EXCEL) for the audit year 2021, we made necessary adaptions to the specification an the OncoBoxes. Changes in the data sheets which have been already shown on OnkoZert-Website are not displayed again, as there is neither an impact on documentation praxis nor the export interface. Please consider that OncoBox Colorectal allows new values in the data field <Grading> (Export of pretherapeutial Grading after neoadjuvant treatment now possible).

In the following table you can check, to which degree the documentation praxis or the export respectively has changed:

*no action to be taken by centre or tumour documentation developer

Application
OncoBox Brust K1.1.1
OncoBox Darm K1.1.1
OncoBox Prostata L1.1.1

Specification
OncoBox Brust Spezifikation K1.1.1
OncoBox Darm Spezifikation K1.1.1
OncoBox Prostata Spezifikation L1.1.1

This update fixes a few smaller bugs. Further, the OncoBox can now generate a data sheet in English. Neither for generating the certification relevant data sheet nor for generating PCO’s study data set an update is necessary.

Application
OncoBox Prostata K1.1.2

Specification
OncoBox Prostata Spezifikation K1.1.2

This update fixes a few smaller bugs and a mistake in calculating indicator no. 4. Further, the OncoBox can now generate a data sheet in English.

Application
OncoBox Brust J1.1.2

Specification
OncoBox Brust Spezifikation J1.1.2

This update fixes a bug in calculating nominator of indicator no. 29. Further, a new histology code (8140/6) was added to the list of valid histology codes.

Application
OncoBox Darm J1.1.2

Specification
OncoBox Darm Spezifikation J1.1.2

Due to changes in the data sheets (EXCEL) fort he audit year 2020, we made necessary adaptions to the specification an the OncoBoxes. Changes in the data sheets which have been already shown on https://www.onkozert.de/2019/05/16/aenderungen-auditvorlagen-auditjahr-2020/ , are not displayed again, as there is neither an impact on documentation praxis nor the export interface. Please beware that for breast a detailled documentation of the gender (analog to „Einheitlicher Onkologischer Basisdatensatz) is necessary.

In the following table you can check, to which degree the documentation praxis or the export respectively has changed:

*no action to be taken by centre or tumour documentation developer

Application
OncoBox Brust J1.1.1
OncoBox Darm J1.1.1
OncoBox Prostata K1.1.1

Specification
OncoBox Brust Spezifikation J1.1.1
OncoBox Darm Spezifikation J1.1.1
OncoBox Prostata Spezifikation K1.1.1

For the next data transfer in the framework of the PCO study in 2020, requirements on the quality of the data sets were increased on the basis of the global data coordination centre’s feedback. For that reasons, we have changed some conspicuities into documentation deficits. We recommend Prostate Cancer Centres which take part at the PCO study to use this version as he new logic applies to all study patients from the past, too. The new documentation deficits are shown in the document below “Neue Dokumentationsdefizite”.

Please beware that this is not the OncoBox version for the audit year 2020.

Application
OncoBox Prostata J1-1.5
Beschreibung des Updates J1-1.5 (Neue Dokumentationsdefizite)

Specification
OncoBox Prostata Spezifikation J1-1.5

This update fixes a bug which occurs at the datasheet (sheet “PCO-Teilnahmequote”). The calculations of the cut-off date is also changed. PCO-Centres have to use this version of the OncoBox to generate the datasheet. For the up-do-date data transfer period, a new installation is not necessary.

Application
OncoBox Prostata J1-1.4

Specification
OncoBox Prostata Spezifikation J1-1.4

Changes in the OncoBox were triggered by a global meeting of PCO data managers at the beginning of March in Los Angeles. For this version, we have implemented as far as possible the new requirements to data quality which were presented in LA.
Along with this version, you will find following changes:

• Differentiation between references on data quality (=conspicuities) and obligatory adjustment requirements (=documentation deficit).
• Automatized display of the analytical protocol which enables the centres to check the data set before sending it to OnkoZert.

We recommend to Prostate Cancer Centres which take part at the PCO study use this new version.

Application
OncoBox Prostata J1-1.3
Beschreibung des Updates J1-1.3

Specification
OncoBox Prostata Spezifikation J1-1.3

This update fixes a bug which occurs at the datasheet (indicator 20, data quality). There are no changes at the calculations of the OncoBox. Centres have to use this version of the OncoBox Breast to generate the datasheet.

Application
OncoBox Brust I2-1.2

Specification
OncoBox Brust Spezifikation I2-1.2

This update fixes a bug which occurs while exporting the datasheet, specifically the table for PCO centres. There are no changes at the calculations of the OncoBox. Prostate cancer centres participating in the PCO study must use this version of the OncoBox Prostate to generate the datasheet.

Application
OncoBox Prostata J1-1.2

Specification
OncoBox Prostata Spezifikation J1-1.2

This update fixes following bugs. For the calculation of transanal full-thickness resections, the second place after the comma is also allowed. Further, a conceptual failure in quality indicator no. 29 (R local, not R total, is decisive for the diagnostic report’s completeness. Finally, there was an uncertainty in exporting the EDIUM study patients. Thanks for the quick feedback. This allowed us to develop this update quickly.

Application
OncoBox Darm I1-1.2

Specification
OncoBox Darm Spezifikation I1-1.2

Due to adaptions in the data sheet (EXCEL file) for the audit year 2018 we had to change OncoBox Colorectal. As the XML schemes have not changed, software developers do not have to adapt the interface between their tumour documentation system and the OncoBoxes. Out of the new, optional quality indicators (10, 24b, 24c, 25a, 25c, 27, 29), only no. 29 will be calculated by the OncoBox.

Further, we added additional functionalities which are necessary to manage the EDIUM study. If you import both the XML file from your tumour documentation systems (medical record) and the XML file from www.edium-studie.de (survey data), you will find additional reports in the new menu “EDIUM” (pre- and posttherapeutical return rate). In the export for the certification relevant data you will find the new spreadsheet “EDIUM-Teilnahmequote” (pretherapeutical return rate on a quarterly level). We will give more information on these new exports to EDIUM study centres separately.

Centres which do not take part at the EDIUM study, import the XML file from their tumour documentation system only and leave out importing survey data.

Application
OncoBox Darm I1-1.1

Specification
OncoBox Darm Spezifikation I1-1.1

Due to adaptions in the data sheet (EXCEL file) for the audit year 2019 we had to change OncoBox Breast and Prostate. As the XML schemes have not changed, software developers do not have to adapt the interface between their tumour documentation system and the OncoBoxes. The applications for the audit year 2019 are published below, too.

Due TNGR’s (formerly known as PCO study) global data coordination centre’s feedback, we have added some plausibility checks (conspicuities). Please take into account that the corrections of these conspicituties is mandatory for a successful transfer of study data.

Applications
OncoBox Brust I2-1.1
OncoBox Prostata J1-1.1

Specifications
OncoBox Brust Spezifikation I2-1.1
OncoBox Prostata Spezifikation J1-1.1